Rapid decline in estimated glomerular filtration rate in sickle cell anemia: results of a multicenter pooled analysis

Saved in:
Bibliographic Details
Published inHaematologica (Roma) Vol. 106; no. 6; pp. 1749 - 1753
Main Authors Ataga, Kenneth I., Zhou, Qingning, Derebail, Vimal K., Saraf, Santosh L., Hankins, Jane S., Loehr, Laura R., Garrett, Melanie E., Ashley-Koch, Allison E., Cai, Jianwen, Telen, Marilyn J.
Format Journal Article
LanguageEnglish
Published Fondazione Ferrata Storti 01.06.2021
Ferrata Storti Foundation
Subjects
Letters to the Editor
Online AccessGet full text

Cover

More Information
Bibliography:SourceType-Other Sources-1
ObjectType-Article-2
content type line 63
ObjectType-Correspondence-1
Disclosures: KIA has received funding from the US FDA (R01FD006030), Novartis, and Global Blood Therapeutics, served on advisory boards for Novartis, Global Blood Therapeutics, Novo Nordisk and Editas Medicine, and as a consultant for Roche. Dr. Derebail has received funding from the US FDA (R01FD006030), has served on advisory boards for Novartis and Retrophin. SLF has received research funding from Novartis, Global Blood Therapeutics and Pfizer and served as a consultant role for Global Blood Therapeutics and advisory board for Novartis. JSH receives research funding from Global Blood Therapeutics, and consultant fees from Global Blood Therapeutics and MJ Lifesciences. MJT has served on steering committees and advisory committees for Pfizer, GlycoMimetics, Novartis, and Forma Therapeutics. JC has received funding from the FDA (R01FD006030). KIA, VKD, LL, JC received funding for the study from the US Food and Drug Administration (R01FD006030).
Contributions: KIA designed the study, analyzed the data and wrote the manuscript; QZ and JC analyzed the data, and assisted in study design and manuscript preparation; MEG assisted in data analysis and manuscript preparation; VKD, SLS, JSH, LRL, AEA-K and MJT assisted in study design, data analysis and manuscript preparation.
ISSN:0390-6078
1592-8721
DOI:10.3324/haematol.2020.267419